NCT04009330 - Clinical Evaluation of a Point of Care (POC) Assay to Identify Phenotypes in the Acute Respiratory Distress Syndrome | Biotech Hunter

Enrollment

480

Participants

Timeline

Start Date

November 22, 2019

Primary Completion Date

November 27, 2023

Study Completion Date

February 27, 2026

Conditions

Acute Respiratory Distress Syndrome (ARDS)

Interventions

DIAGNOSTIC_TEST

POC Assay

"Interventions:~Blood Baseline - up to 40ml Day 3 - up to 40ml~Urine Baseline - 10ml Day 3 - 10ml~Study population:~Adults (18 plus) in ICU units diagnosed with ARDS."

Trial Locations (22)

D04 T6F4

St Vincents Hospital, Dublin

B15 2TH

University Hospital Birmingham, Birmingham

BB2 3HH

Royal Blackburn Hospital, Blackburn

L7 8XP

Royal Liverpool University Hospital, Liverpool

NW1 2BU

University College London, London

SE1 7EH

Guys and St Thomas Hospital, London

SE5 9RS

Kings College Hospital, London

M23 9QZ

Wythenshawe Hospital, Manchester

Unknown

Manchester Royal Infirmary, Manchester

Freemans Hospital, Newcastle upon Tyne

Royal Victoria Hospital, Belfast

Imperial College London, London

Oxford University Hospitals, Oxford

NG7 2UH

Nottingham University Hospital, Nottingham

RG1 5AN

Royal Berkshire Hospital, Reading

SR4 7TP

Sunderland Royal, Sunderland

TR1 3LI

Royal Cornwall Hospital, Truro

EH16 4SB

Edinburgh Royal Infirmary, Edinburgh

G31 2ER

Glasgow Royal Infirmary, Glasgow

CF14 4XW

University Hospital of Wales, Cardiff

NP18 3XQ

Royal Gwent Hospital, Newport

B9 5SS

Birmingham Heartlands Hospital, Birmingham